BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 16889960)

  • 21. Design, synthesis and biological evaluation of piperazine analogues as CB1 cannabinoid receptor ligands.
    Song KS; Lee SH; Chun HJ; Kim JY; Jung ME; Ahn K; Kim SU; Kim J; Lee J
    Bioorg Med Chem; 2008 Apr; 16(7):4035-51. PubMed ID: 18243711
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemical modification of the naphthoyl 3-position of JWH-015: in search of a fluorescent probe to the cannabinoid CB2 receptor.
    Yates AS; Doughty SW; Kendall DA; Kellam B
    Bioorg Med Chem Lett; 2005 Aug; 15(16):3758-62. PubMed ID: 15993070
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of CoMFA and CoMSIA models of affinity and selectivity for indole ligands of cannabinoid CB1 and CB2 receptors.
    De Freitas GB; da Silva LL; Romeiro NC; Fraga CA
    Eur J Med Chem; 2009 Jun; 44(6):2482-96. PubMed ID: 19249138
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel sterically hindered cannabinoid CB1 receptor ligands.
    Urbani P; Cascio MG; Ramunno A; Bisogno T; Saturnino C; Di Marzo V
    Bioorg Med Chem; 2008 Aug; 16(15):7510-5. PubMed ID: 18579386
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design, synthesis, biological properties, and molecular modeling investigations of novel tacrine derivatives with a combination of acetylcholinesterase inhibition and cannabinoid CB1 receptor antagonism.
    Lange JH; Coolen HK; van der Neut MA; Borst AJ; Stork B; Verveer PC; Kruse CG
    J Med Chem; 2010 Feb; 53(3):1338-46. PubMed ID: 20047331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tricyclic pyrazoles. Part 6. Benzofuro[3,2-c]pyrazole: a versatile architecture for CB2 selective ligands.
    Pinna G; Loriga G; Lazzari P; Ruiu S; Falzoi M; Frau S; Pau A; Murineddu G; Asproni B; Pinna GA
    Eur J Med Chem; 2014 Jul; 82():281-92. PubMed ID: 24922543
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 1,2,3-Triazole derivatives as new cannabinoid CB1 receptor antagonists.
    Hou DR; Alam S; Kuan TC; Ramanathan M; Lin TP; Hung MS
    Bioorg Med Chem Lett; 2009 Feb; 19(3):1022-5. PubMed ID: 19095444
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design and synthesis of a novel series of N-alkyl isatin acylhydrazone derivatives that act as selective cannabinoid receptor 2 agonists for the treatment of neuropathic pain.
    Diaz P; Xu J; Astruc-Diaz F; Pan HM; Brown DL; Naguib M
    J Med Chem; 2008 Aug; 51(16):4932-47. PubMed ID: 18666769
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Probing the cannabinoid CB1/CB2 receptor subtype selectivity limits of 1,2-diarylimidazole-4-carboxamides by fine-tuning their 5-substitution pattern.
    Lange JH; van der Neut MA; Borst AJ; Yildirim M; van Stuivenberg HH; van Vliet BJ; Kruse CG
    Bioorg Med Chem Lett; 2010 May; 20(9):2770-5. PubMed ID: 20363132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 1-Benzhydryl-3-phenylurea and 1-benzhydryl-3-phenylthiourea derivatives: new templates among the CB1 cannabinoid receptor inverse agonists.
    Muccioli GG; Wouters J; Scriba GK; Poppitz W; Poupaert JH; Lambert DM
    J Med Chem; 2005 Nov; 48(23):7486-90. PubMed ID: 16279809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural modifications of the cannabinoid side chain towards C3-aryl and 1',1'-cycloalkyl-1'-cyano cannabinoids.
    Papahatjis DP; Nahmias VR; Andreou T; Fan P; Makriyannis A
    Bioorg Med Chem Lett; 2006 Mar; 16(6):1616-20. PubMed ID: 16387492
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacomodulations around the 4-oxo-1,4-dihydroquinoline-3-carboxamides, a class of potent CB2-selective cannabinoid receptor ligands: consequences in receptor affinity and functionality.
    Stern E; Muccioli GG; Bosier B; Hamtiaux L; Millet R; Poupaert JH; Hénichart JP; Depreux P; Goossens JF; Lambert DM
    J Med Chem; 2007 Nov; 50(22):5471-84. PubMed ID: 17915849
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and biological evaluation of new N-alkyl 1-aryl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamides as cannabinoid receptor ligands.
    Silvestri R; Ligresti A; La Regina G; Piscitelli F; Gatti V; Lavecchia A; Brizzi A; Pasquini S; Allarà M; Fantini N; Carai MA; Bigogno C; Rozio MG; Sinisi R; Novellino E; Colombo G; Di Marzo V; Dondio G; Corelli F
    Eur J Med Chem; 2010 Dec; 45(12):5878-86. PubMed ID: 20943290
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Scaffold hopping strategy toward original pyrazolines as selective CB₂ receptor ligands.
    Gembus V; Furman C; Millet R; Mansouri R; Chavatte P; Levacher V; Brière JF
    Eur J Med Chem; 2012 Dec; 58():396-404. PubMed ID: 23151320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent developments in the medicinal chemistry of cannabimimetic indoles, pyrroles and indenes.
    Huffman JW; Padgett LW
    Curr Med Chem; 2005; 12(12):1395-411. PubMed ID: 15974991
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 4-Oxo-1,4-dihydropyridines as selective CB2 cannabinoid receptor ligands: structural insights into the design of a novel inverse agonist series.
    El Bakali J; Muccioli GG; Renault N; Pradal D; Body-Malapel M; Djouina M; Hamtiaux L; Andrzejak V; Desreumaux P; Chavatte P; Lambert DM; Millet R
    J Med Chem; 2010 Nov; 53(22):7918-31. PubMed ID: 20979417
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Substituted pyrimidines as cannabinoid CB1 receptor ligands.
    Kim MJ; Kim JY; Seo HJ; Lee J; Lee SH; Kim MS; Kang J; Kim J; Lee J
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4692-7. PubMed ID: 19596576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Homology models of the cannabinoid CB1 and CB2 receptors. A docking analysis study.
    Montero C; Campillo NE; Goya P; Páez JA
    Eur J Med Chem; 2005 Jan; 40(1):75-83. PubMed ID: 15642412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potent cannabinergic indole analogues as radioiodinatable brain imaging agents for the CB1 cannabinoid receptor.
    Deng H; Gifford AN; Zvonok AM; Cui G; Li X; Fan P; Deschamps JR; Flippen-Anderson JL; Gatley SJ; Makriyannis A
    J Med Chem; 2005 Oct; 48(20):6386-92. PubMed ID: 16190764
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New 1,2,3,4-tetrahydropyrrolo[3,4-b]indole derivatives as selective CB2 receptor agonists.
    Pagé D; Yang H; Brown W; Walpole C; Fleurent M; Fyfe M; Gaudreault F; St-Onge S
    Bioorg Med Chem Lett; 2007 Nov; 17(22):6183-7. PubMed ID: 17884494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.